Skip to main content

人類用藥創新
Human Health Innovation

我們的目標很明確。我們希望提供一系列突破性藥物，以改善全球患者的生活，從創新開始。

Boehringer Ingelheim is clear about its goals. We want to deliver a portfolio of breakthrough medicines that will improve the lives of patients around the word. That starts with innovation.
shutterstock

最新動向

research_development_banner

研究發展中項目
Research and Development Pipeline

憑藉大約 100 個臨床和臨床前進行中項目，以及 2025 年提供 15 個以上新藥批准的潛力，我們繼續保持以創新為長期發展的主導。
With a pipeline of around 100 clinical and pre-clinical projects, and the potential to deliver up to 15 new medicine approvals by 2025, we continue our track record of long-term innovation-led performance.

更多資訊
AdobeStock508248788.jpeg
人類處方用藥 創新

“Rapid progress towards clinical candidates”

Michel Pairet, Member of the Board of Managing Directors, explains why Boehringer Ingelheim expands its commitment to fighting drug resistant infections with a new joint venture.
更多資訊